Getting from a fragment to
something more useful can be time consuming, and frustrating. Often it requires
making lots of inactive analogs. It is easy to set up multiple chemical
reactions in parallel, but purifying products is tedious. Thus, there has been a trend towards screening crude reaction
mixtures. Off-rate screening (ORS) using SPR was published back in 2014, and
other techniques have been used as well. Now, two recent papers describe using
crystallography as the assay.
In a J. Med. Chem. paper, Bradley
Doak, Martin Scanlon, and collaborators at Monash University, La Trobe
University, University of Wollongong, and Queensland University of Technology
describe Rapid Elaboration of Fragments into Leads using X-ray crystallography
(REFiLx; see also here). The researchers note that ORS is best for
identifying reasonably potent compounds, with low (<10) micromolar potency
or better. For some targets, this is a bar too high. Specifically, they were
interested in E. coli disulfide bond forming protein A (EcDsbA),
an anti-virulence target for which they had found – after considerable effort –
a 490 µM fragment.
The fragment contained a
carboxylic acid, which could be conveniently used for amide bond formation, and
the researchers decided to make a bespoke library around it. A collection of 93
small (5-12 heavy atoms) amines was assembled and each member was reacted with
2 micromoles (about 0.5 mg) of the fragment in a 96 well plate. The reactions
were then evaporated and dissolved in DMSO to 100 mM concentration (assuming
the reactions went to completion). HPLC-MS analyses revealed likely product for
83 reactions with yields up to 90%, though the average was closer to 25%. These
crude reaction mixtures were then soaked into previously grown crystals of EcDsbA
and analyzed crystallographically using both manual and automatic processing
(including PanDDA).
The result was four hits, all of
which were resynthesized and characterized in detail. Crystallography of the
pure compounds confirmed the binding modes found in the crude reaction mixtures.
Gratifyingly, one of the compounds bound 8-fold more tightly than the initial
fragment, as assessed by two dimensional NMR.
The four hits all had purities
>50% in the crude reaction mixtures, so the researchers resynthesized a few
other non-hits that had lower yields. One of these was about 2-fold better than
the original fragment, suggesting a false negative in the first screen.
Experiments in which the most active hit was spiked into faux reaction mixtures
at increasingly lower concentrations revealed – as expected – that detection
was more difficult at lower concentrations.
A similar approach is described
in Communications Chemistry by Rod Hubbard and collaborators at
Vernalis, University of York, Diamond Light Source, University of Oxford, and
University of Johannesburg. However, whereas the first paper focuses on trying
to find improved hits against a difficult target, this paper focuses more on
methodology. The researchers used two of the same protein targets for which
they had previously performed off-rate screening, HSP90 and PDHK2.
Conveniently, both these ATPases share some inhibitors, so the same set of 83 crude
reaction mixtures could be used for both enzymes. Also in contrast to the EcDsbA
example, the starting fragments (found in prior screens) were considerably more
potent, as were the final molecules.
The researchers note that “as
with any high-throughput experimental approach, there are false positives and
false negatives.” Because off-rates were measured for all the crude reaction
mixtures, the researchers could assess false positives and false negatives
in the crystallographic screens. In false positives, products were seen in the crystal
structures even though their affinities were no better than the reactant. In false negatives,
starting material was seen in the crystal structures even though the products had
better affinities. Together, these accounted for about half the results. Digging
into the details, poor reaction yields and low solubility for the products
accounted for many of the false negatives. False positives are harder to explain,
though the researchers note that the buffer used for crystal soaking is
different from that used for SPR.
There were also some notable
successes: for one racemic compound, crystals of PDHK2 “correctly” selected the
more potent enantiomer (Kd = 0.14 µM) over the less potent one (Kd
= 17 µM). As in the first paper, there is a wealth of experimental details,
including improvements to PanDDA protocols. The researchers performed the soaks
in triplicate, and although this did lead to an increased number of hits, they
note that singleton screening would probably be sufficient for most
applications.
At the CHI FBDD meeting last
month Frank von Delft, who is an author of the second paper, noted that he is
increasingly using crude reaction screening to progress fragments, including
against SARS-CoV-2. I look forward to seeing this approach, and the
leads that come from it, advance.
No comments:
Post a Comment